Quarterly report pursuant to Section 13 or 15(d)

Subsequent Event

Subsequent Event
3 Months Ended
Mar. 31, 2014
Subsequent Events [Abstract]  
Subsequent Event

9. Subsequent Event

In April 2014, the Chief Executive Officer and sole owner of LPThera LLC, Al Fosmoe became an employee of Oragenics. Mr. Fosmoe was previously a consultant to the Company.

In December 2013, we entered into an exclusive licensing agreement for our LPT3-04 weight-loss product candidate with LPThera LLC for further development of this technology.